Suppr超能文献

腺苷脱氨酶在渗出性胸腔积液中的诊断效用

Diagnostic utility of adenosine deaminase in exudative pleural effusions.

作者信息

Mehta Asmita A, Gupta Amit Satish, Ahmed Subin, Rajesh V

机构信息

Department of Pulmonary Medicine, Amrita Institute of Medical Sciences, Kochi, Kerala, India.

出版信息

Lung India. 2014 Apr;31(2):142-4. doi: 10.4103/0970-2113.129842.

Abstract

OBJECTIVE

To determine the diagnostic utility of adenosine deaminase (ADA) in exudative pleural effusions of different etiologies.

SETTING AND DESIGN

It was an observational study conducted at a tertiary care teaching institute.

MATERIALS AND METHODS

Of a total of 171 pleural fluid samples, 122 were found to be exudates and were included in the study. Pleural fluid ADA was done for all included patients. Pleural fluid ADA ≥40 U/l was taken as diagnostic cut off for TB effusion.

STATISTICAL ANALYSIS

Sensitivity, specificity positive and negative predictive value of pleural fluid ADA for diagnosing TB was calculated by using clinical calculator - 1, Richard Lowry 2001-2013.

RESULTS

There were 171 patients with pleural effusion, out of which 122 (71.8%) were found to be exudative and were studied further. There were 49 (40.1%), 36 (29.5%) and 33 (27%) cases of TB, malignancy and para pneumonic effusion respectively, whereas 4 (3.3%) cases remained undiagnosed. Median ADA values for TB, malignancy and para pneumonic effusion were 55.8 U/l (range 9.7-756 U/l), 18 U/l (6.5-81 U/l) and 25 U/l (3.4-172 U/l) respectively. Pleural fluid ADA >40U/l yielded 85.7% sensitivity, 80.8% specificity, 75% positive predictive value and 89.5% negative predictive value.

CONCLUSION

Pleural fluid ADA remains useful in diagnosing tuberculosis pleural effusion. The median ADA for TB effusion in present cohort was 51.8 IU/ml. Pleural fluid ADA of 40 U/L yielded 89.5% negative predictive value and 75% positive predictive value. Pleural fluid ADA is cost effective and good screening test for diagnosis of TB.

摘要

目的

确定腺苷脱氨酶(ADA)在不同病因渗出性胸腔积液中的诊断效用。

设置与设计

这是一项在三级医疗教学机构进行的观察性研究。

材料与方法

在总共171份胸腔积液样本中,发现122份为渗出液并纳入研究。对所有纳入患者进行胸腔积液ADA检测。胸腔积液ADA≥40 U/l被作为结核性胸腔积液的诊断临界值。

统计分析

使用临床计算器-1(Richard Lowry 2001 - 2013)计算胸腔积液ADA诊断结核病的敏感性、特异性、阳性预测值和阴性预测值。

结果

有171例胸腔积液患者,其中122例(71.8%)为渗出液并进一步研究。分别有49例(40.1%)、36例(29.5%)和33例(27%)为结核、恶性肿瘤和类肺炎性胸腔积液病例,而4例(3.3%)病例仍未确诊。结核、恶性肿瘤和类肺炎性胸腔积液的ADA中位数分别为55.8 U/l(范围9.7 - 756 U/l)、18 U/l(6.5 - 81 U/l)和25 U/l(3.4 - 172 U/l)。胸腔积液ADA>40 U/l时,敏感性为85.7%,特异性为80.8%,阳性预测值为75%,阴性预测值为89.5%。

结论

胸腔积液ADA在诊断结核性胸腔积液中仍然有用。本队列中结核性胸腔积液的ADA中位数为51.8 IU/ml。胸腔积液ADA为40 U/L时,阴性预测值为89.5%,阳性预测值为75%。胸腔积液ADA是诊断结核病的一种经济有效且良好的筛查试验。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cf6c/3999674/0f1ee70ffcde/LI-31-142-g002.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验